AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Additional Treatment With NMES After Achilles Tendon Rupture

RecruitingNAAges 18 Years - 65 YearsAllVastra Gotaland Region
💬

In plain words

What the trial is, and whether it could suit you

Increased knowledge is needed about new methods how to treat patients with Achilles tendon ruptures (ATR). A goal is to be able to individualize as well as improve treatment beyond the question about if surgery should be used or not. An overall aim of the project is to, in a randomized controlled trial (RCT), explore what impact a new treatment method with Neuromuscular Electrical Stimulation (NMES) - attached on the patients ́ calf muscles on the injured leg - in the early stages after an ATR, may have on tendon length, functional performance, biomechanical variables and patient reported outcome, both in the short and long term after the injury. 70 patients are planned to be included in this RCT and will be evaluated 3,6 and 12 months after their injury. Primary outcome will be heel-rise height. Secondary outcome will be tendon length, jumping ability, patient- reported outcome and bio

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Achilles Tendon rupture * The injury should have been treated within two days from the trauma * The rupture is located in the mid portion of the tendon Exclusion Criteria: * Pregnancy * Having a pace maker, intra cardiac defibrillator or other active implant * Having had an Achilles Tendon rupture before, regardless of side * Having an earlier injury that will have an impact on lower leg function, regardless of side * Diabetes * Neuro vascular disease * Immunosuppressive treatment * Difficulties to understand the language or difficulties in understand instructions. * Unable to consent
💊

What it tests

  • Neuromuscular electrical stimulation (NMES)
📍

Where

1 site
Forskningsenhet Ortopedi, Sahlgrenska universitetssjukhuset, Mölndal
Mölndal, Sweden
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy